Quality of Life and Technology Assessment (1989) / Chapter Skim
Currently Skimming:
5. The Use of Quality-of-Life Measures in the Private Sector
5. The Use of Quality-of-Life Measures in the Private Sector
Pages 55-64
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 55... ...
Although we emphasize Be private sector, most published accounts to date have been supported by Me public sector, usually fi~nded by government agencies Bough universities. As discussed below, this trend may be changing.
|
From page 56... ...
In a double-blind study at 14 centers, He effects of auranofin were compared win Lose of a placebo in tile treatment of patients win classic or definite rheumatoid arthritis. The auranofin group, as a whole, experienced relatively higher frequencies of adverse effects, but such events were usually mild and transient More importantly, *
|
From page 57... ...
Nevertheless, FDA of fiches express interest In better understanding quality of life, although Hey consider the state of the art too immature to warrant mandatory inclusion in clinical teals. This is not to suggest that He FDA has entirely dismissed quality of life as a potentially import factor in clinical teals.
|
From page 58... ...
The FDA is particularly skeptical of vague claims and has objected in the past to assertions mat a drug is "padent-fnendly." Private Industry Perspective Some spokespersons in the private sector were forthcoming in responding to questions about Heir use of quality~f-life instruments in clinical Dials; others were reluctant, a result of He highly competitive nature of pnv ate industry. Based on informal and formal conversations with research scientists at several pharmaceutical companies, we determ~ned that researchers in the private sector share a general interest in the use of these measures in clinical Dials.
|
From page 59... ...
and the Heath Industry Manufacturers Association (HIMA) , BatteDe conducted a survey of pharmaceutical and medical companies to determine how widely quality-of-life instruments are being used in the private sector.
|
From page 60... ...
WESCH~:R, AND C UNDERWOOD TABLE 5-1 Highlights of Survey Results on Q;uality~f-Life Measurement by Pharmaceutical Fames Company Actrvity Total Number of Number Con~parues Reporting Percent Companies Using Qualib~of-Life Instrument Have used 34 21 62 Are currency using 34 20 59 Reasons for use 21 1.
|
From page 61... ...
Among Hose listed are the Beck Depression Inventory, Dupuy Life Satisfaction, Wechsler Memos Scale, Fleming Self-Esteem Hospice Anxiety and Depression Scale, and Women's Heath Questionnaire. Fourteen (67 percent)
|
From page 62... ...
A second mailing conducted by HIMA yielded no additions responses from He sample of medical device companies. That ~ree-qua~ters of the medical device companies did not respond to He questionnaire suggests low salience and sparse usage of quality~f-life instruments in the device sector, especially compared win the drug sector.
|
From page 63... ...
Depression arid body image following mastectomy and lumpectomy. Journal of Chronic Diseases 40~6~:529-534, 1987.
|
From page 64... ...
What conshmms quality of life? A concepmalizabon of me dimensions of life quality In hearty populations and patients win cardiovascular disease.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.